Global Health (MEDANTA) Share Price Falls 2.16%: Medanta Slides to Rs 1,463

Published:   28 September 2026 at 9:54:34 AM IST

Global Health Share Price declined to Rs 1,463 today, down 2.16% from the previous close of Rs 1,495.3. The company’s market capitalisation stands at Rs 40,204.85 crore, placing Medanta in the Large Cap category. The move is relevant because the supply of verified data confirms a same-day price fall, but it does not establish a company-specific catalyst. For readers tracking Global Health Share Price Today, the key question is how today’s decline fits with the stock’s valuation, healthcare sector context and peer comparisons. This Global Health Stock News update focuses only on the facts supplied in the data and avoids guessing a trigger. Univest is using the verified numbers to frame the event in a clear, research-style format.

Global Health (MEDANTA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,463
Previous Close	Rs 1,495.3
Today's Move	-Rs 32.30 (-2.16%)
Open	Rs 1,500
High	Rs 1,500
Low	Rs 1,455
Turnover	Rs 0.14 crore
Market Capitalisation	Rs 40,204.85 crore
Market Cap Category	Large Cap

Global Health Share Price opened at Rs 1,500, touched an intraday high of Rs 1,500 and a low of Rs 1,455 before closing at Rs 1,463. That means the stock finished Rs 32.3 lower than the previous close, a decline of 2.16% on the day. The day’s range shows that the session moved between the opening level and the lower end of the band before settling near the close. Turnover for the session was Rs 0.14 crore. The company’s market-cap category is Large Cap, and the latest market capitalisation is Rs 40,204.85 crore. From a pure price-action standpoint, today’s Global Health Share Price Fall reflects a lower close after an opening level of Rs 1,500, with the final print at Rs 1,463. The supplied data confirms the price event, but it does not establish a company-specific reason for the decline. Investors following Global Health Share Price Today can next compare this move with the stock’s valuation and sector metrics.

Global Health (MEDANTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 40,204.85 crore
P/E Ratio	72.29x
P/B Ratio	9.78x
ROE	15.12%
ROCE	19.38%
EPS	Rs 20.69
Book Value Per Share	Rs 152.94
Dividend Yield	0.03%

The valuation line-up also matters for Global Health Share Price Today. With a P/E of 72.29 and P/B of 9.78, Medanta trades at levels that should be viewed in relation to its own sector rather than in isolation. ROE of 15.12 and ROCE of 19.38 are useful quality markers, while EPS of Rs 20.69 and book value of Rs 152.94 provide per-share context that helps explain the company’s financial base. The dividend yield of 0.03 is also important because it shows that the stock is not being presented here as a yield-led story. Univest readers typically use these measures to understand whether a same-day decline changes the longer-term equity story or simply reflects a short-term price move. In this case, the data supports the move itself and the fundamentals behind the stock, but not a specific event driver.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	72.29x
Benchmark Median P/E	47.93x
Benchmark Average P/E	102.02x
Benchmark P/E Range	7.02x to 1,602.7x
Company P/B Ratio	9.78x
Benchmark Median P/B	3.32x
Benchmark Average P/B	4.24x
Company ROE	15.12%
Benchmark Median ROE	12.88%
Benchmark Average ROE	12.28%
Company ROCE	19.38%
Benchmark Median ROCE	15.77%
Benchmark Average ROCE	2.85%
Company Market Capitalisation	Rs 40,204.85 crore
Benchmark Median Market Cap	Rs 499.52 crore
Benchmark Average Market Cap	Rs 11,141.18 crore

The healthcare sector and the hospital & healthcare services industry provide the benchmark for Global Health Share Price. The supplied comparison set covers 67 companies in the same industry, which gives enough context to compare valuation and returns with a relevant peer universe. Global Health ’s P/E of 72.29 is above the industry median of 47.93 and below the benchmark average of 102.02. Its P/B of 9.78 is above the sector median of 3.32 and above the benchmark average of 4.24. On profitability metrics, ROE at 15.12 is above the industry median of 12.88, while ROCE at 19.38 is above the industry median of 15.77. That combination makes the stock’s valuation richer than the median company in the set, while the return ratios also sit above the median benchmark. In market-cap terms, Global Health at Rs 40,204.85 crore is well above the industry median market cap of Rs 499.52 crore and below the benchmark average of Rs 11,141.18 crore because the distribution includes a few very large names. Univest uses this sector frame to show how Medanta compares within healthcare rather than as a standalone stock.

The industry data also shows the spread in valuations across healthcare is wide. The P/E range stretches from 7.02 to 1,602.7, while the P/B range runs from -11.34 to 15.65. Against that backdrop, Global Health Share Price sits on a company with a valuation profile that is clearly not at the low end of the industry. The same is true for ROE and ROCE, where the company remains above the median benchmark but not the highest in the set. For investors scanning Global Health Stock Analysis, the key point is that today’s fall does not erase the company’s premium positioning on valuation ratios or its above-median return ratios. Univest presents the benchmark scope and exact comparison values so readers can keep the share price move in context.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,27,823.12	61.17	13.2	23.54	21.73
Max Healthcare Institute	MAXHEALTH	98,693.66	67.74	9.03	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	95,621.35	107.16	5.24	12.95	13.93
Aster DM Healthcare	ASTERDM	66,181.73	207.67	15.65	13.07	16.22
Fortis Healthcare	FORTIS	63,046.55	60.17	6.2	11.32	14.07

Global Health Share Price can be compared with a small set of listed healthcare peers supplied in the data. Among the peer group, Apollo Hospitals Enterprise has a higher market cap of Rs 1,27,823.12 crore, a P/E of 61.17, P/B of 13.2, ROE of 23.54 and ROCE of 21.73. Max Healthcare Institute shows a market cap of Rs 98,693.66 crore, P/E of 67.74, P/B of 9.03, ROE of 14.53 and ROCE of 14.97. Fortis Healthcare is at Rs 63,046.55 crore market cap with P/E of 60.17, P/B of 6.2, ROE of 11.32 and ROCE of 14.07. Narayana Hrudayalaya has a market cap of Rs 38,040.74 crore, P/E of 46.61, P/B of 8.01, ROE of 19.86 and ROCE of 16.2. Medanta’s market cap is above Narayana Hrudayalaya and below the larger peers, while its P/E and P/B are higher than most of the supplied comparisons.

On returns, Global Health sits between the strongest and weaker peer figures in the list. Its ROE of 15.12 is below Apollo Hospitals and Narayana Hrudayalaya, but above Max Healthcare and Fortis. Its ROCE of 19.38 is also above Max Healthcare and Fortis, while remaining below Apollo Hospitals and Narayana Hrudayalaya. For readers following Global Health Share Price Today, the peer set shows that Medanta trades with a richer multiple than several comparables, while its profitability ratios are competitive rather than dominant. Univest uses this peer frame to show how the stock is positioned within the listed hospital and healthcare services space.

Why Investors Are Watching Global Health

• Global Health Share Price declined 2.16% today to Rs 1,463.
• The previous close was Rs 1,495.3, while the day open was Rs 1,500.
• Today’s low was Rs 1,455 and the day high was Rs 1,500.
• Market capitalisation stands at Rs 40,204.85 crore, and the stock is in the Large Cap category.
• The healthcare industry benchmark shows a P/E median of 47.93, while Global Health trades at 72.29.

About Global Health

Global Health operates in the Healthcare sector and the Hospital & Healthcare Services industry. The supplied data places the company in a large listed universe that is benchmarked against 67 peers in the same industry. For readers tracking Global Health Stock News, the important company-level facts in this article are the current market capitalisation of Rs 40,204.85 crore, the P/E ratio of 72.29, the P/B ratio of 9.78, ROE of 15.12, ROCE of 19.38, EPS of Rs 20.69, book value of Rs 152.94 and dividend yield of 0.03. Univest presents these numbers as a factual company profile alongside the day’s price move.

Track Global Health Share Price on Univest

Use Global Health (MEDANTA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Univest lets readers track Global Health Share Price, Global Health Share Price Today and Global Health Share Price Live with the same verified framework used in this article. You can also review Global Health Shareholding Pattern, key fundamental ratios, market cap context, 52-week levels and company updates in one place.

Frequently Asked Questions

Why did Global Health Share Price fall today?

Ans.  The data confirms that Global Health Share Price fell 2.16% today to Rs 1,463, but it does not establish a company-specific catalyst. The move is supported by the day’s price data, not a verified reason.

What is Global Health Share Price today?

Ans.  Global Health Share Price today is Rs 1,463. It declined Rs 32.3 from the previous close of Rs 1,495.3, and the session opened at Rs 1,500 before touching a low of Rs 1,455.

What is Global Health market capitalisation?

Ans.  Global Health has a market capitalisation of Rs 40,204.85 crore. The data also places it in the Large Cap category, which is useful context for understanding the stock’s scale in the listed market.

How is Global Health valued on earnings and book value?

Ans.  Global Health has a P/E ratio of 72.29 and a P/B ratio of 9.78. EPS is Rs 20.69 and book value per share is Rs 152.94, which provides per-share earnings and accounting value context.

How do Global Health fundamentals compare with the healthcare sector?

Ans.  Compared with the same-industry benchmark, Global Health trades above the median P/E of 47.93 and above the median P/B of 3.32. Its ROE of 15.12 and ROCE of 19.38 are also above the medians.

How does Global Health compare with listed peers?

Ans.  In the supplied peer set, Global Health has a higher valuation than several names on P/E and P/B, while its ROE and ROCE sit between the stronger and weaker peer figures. Its market cap is Rs 40,204.85 crore.